![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Diabeloop Receives CE Mark for Blood Sugar Monitoring Technology
Diabeloop Receives CE Mark for Blood Sugar Monitoring Technology
November 14, 2018
Diabeloop’s DBLG1 technology for monitoring and maintaining blood sugar levels has earned the CE Mark.
The self-learning, customizable system can mimic the pancreas’ insulin-dispensing functions and adapt to the patient.
The DBLG1 links to a continuous blood glucose monitoring system and an insulin patch pump to predict glucose levels and optimally control the pump.
Upcoming Events
-
21Oct